Skip to Main Content

Paper Details

Personalized oncology through integrative high-throughput sequencing: a pilot study.
Sci Transl Med
446
2011
AURKA, CDK, CDK8, CDKN2C, FAS, HRAS, MEK, MYH11, NRAS, PI3K, RNA, Ras, TP53, Tumor, advanced cancer, advanced or refractory cancer, cancer, cancers, cyclin-dependent kinase 8, human, malignant melanoma, metastatic colorectal cancer, patient, patients, phosphatidylinositol, phosphatidylinositol 3-kinase, prostate cancer, protein kinase kinase, tumor, tumor and normal DNA

Datasets

Release 1.2